These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 31107743)

  • 1. 18F-FACBC PET/MRI in Diagnostic Assessment and Neurosurgery of Gliomas.
    Karlberg A; Berntsen EM; Johansen H; Skjulsvik AJ; Reinertsen I; Dai HY; Xiao Y; Rivaz H; Borghammer P; Solheim O; Eikenes L
    Clin Nucl Med; 2019 Jul; 44(7):550-559. PubMed ID: 31107743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of trans-1-amino-3-18F-fluorocyclobutanecarboxylic acid accumulation in low-grade glioma in chemically induced rat models: PET and autoradiography compared with morphological images and histopathological findings.
    Doi Y; Kanagawa M; Maya Y; Tanaka A; Oka S; Nakata N; Toyama M; Matsumoto H; Shirakami Y
    Nucl Med Biol; 2015 Aug; 42(8):664-72. PubMed ID: 26022202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase IIa clinical study of [
    Kondo A; Ishii H; Aoki S; Suzuki M; Nagasawa H; Kubota K; Minamimoto R; Arakawa A; Tominaga M; Arai H
    Ann Nucl Med; 2016 Nov; 30(9):608-618. PubMed ID: 27418267
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Albano D; Tomasini D; Bonù M; Giubbini R; Bertagna F
    Ann Nucl Med; 2020 Feb; 34(2):81-86. PubMed ID: 31773466
    [No Abstract]   [Full Text] [Related]  

  • 5. Multimodal
    Karlberg A; Berntsen EM; Johansen H; Myrthue M; Skjulsvik AJ; Reinertsen I; Esmaeili M; Dai HY; Xiao Y; Rivaz H; Borghammer P; Solheim O; Eikenes L
    World Neurosurg; 2017 Dec; 108():989.e1-989.e8. PubMed ID: 28844925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic accuracy of anti-3-[
    Karlberg A; Pedersen LK; Vindstad BE; Skjulsvik AJ; Johansen H; Solheim O; Skogen K; Kvistad KA; Bogsrud TV; Myrmel KS; Giskeødegård GF; Ingebrigtsen T; Berntsen EM; Eikenes L
    Eur J Nucl Med Mol Imaging; 2024 Jan; 51(2):496-509. PubMed ID: 37776502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determining the extent of tumor resection at surgical planning with
    Wakabayashi T; Hirose Y; Miyake K; Arakawa Y; Kagawa N; Nariai T; Narita Y; Nishikawa R; Tsuyuguchi N; Fukami T; Sasaki H; Sasayama T; Kondo A; Iuchi T; Matsuda H; Kubota K; Minamimoto R; Terauchi T; Nakazato Y; Kubomura K; Wada M
    Ann Nucl Med; 2021 Dec; 35(12):1279-1292. PubMed ID: 34406623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Value of O-(2-[18F]-Fluoroethyl)-L-Tyrosine-Positron Emission Tomography Imaging for Histopathologic Characteristics and Progression-Free Survival in Patients with Low-Grade Glioma.
    Bette S; Gempt J; Delbridge C; Kirschke JS; Schlegel J; Foerster S; Huber T; Pyka T; Zimmer C; Meyer B; Ringel F
    World Neurosurg; 2016 May; 89():230-9. PubMed ID: 26855307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Localized prostate cancer detection with 18F FACBC PET/CT: comparison with MR imaging and histopathologic analysis.
    Turkbey B; Mena E; Shih J; Pinto PA; Merino MJ; Lindenberg ML; Bernardo M; McKinney YL; Adler S; Owenius R; Choyke PL; Kurdziel KA
    Radiology; 2014 Mar; 270(3):849-56. PubMed ID: 24475804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic Value of 18 F-FACBC PET/MRI in Brain Metastases.
    Øen SK; Johannessen K; Pedersen LK; Berntsen EM; Totland JA; Johansen H; Bogsrud TV; Solheim TS; Karlberg A; Eikenes L
    Clin Nucl Med; 2022 Dec; 47(12):1030-1039. PubMed ID: 36241129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-grade glioma radiation therapy target volumes and patterns of failure obtained from magnetic resonance imaging and 18F-FDOPA positron emission tomography delineations from multiple observers.
    Kosztyla R; Chan EK; Hsu F; Wilson D; Ma R; Cheung A; Zhang S; Moiseenko V; Benard F; Nichol A
    Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1100-6. PubMed ID: 24161427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. O-(2-[(18)F]fluoroethyl)-L-tyrosine uptake is an independent prognostic determinant in patients with glioma referred for radiation therapy.
    Sweeney R; Polat B; Samnick S; Reiners C; Flentje M; Verburg FA
    Ann Nucl Med; 2014 Feb; 28(2):154-62. PubMed ID: 24272067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biopsy validation of 18F-DOPA PET and biodistribution in gliomas for neurosurgical planning and radiotherapy target delineation: results of a prospective pilot study.
    Pafundi DH; Laack NN; Youland RS; Parney IF; Lowe VJ; Giannini C; Kemp BJ; Grams MP; Morris JM; Hoover JM; Hu LS; Sarkaria JN; Brinkmann DH
    Neuro Oncol; 2013 Aug; 15(8):1058-67. PubMed ID: 23460322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of 18F-FET PET and perfusion-weighted MR imaging: a PET/MR imaging hybrid study in patients with brain tumors.
    Filss CP; Galldiks N; Stoffels G; Sabel M; Wittsack HJ; Turowski B; Antoch G; Zhang K; Fink GR; Coenen HH; Shah NJ; Herzog H; Langen KJ
    J Nucl Med; 2014 Apr; 55(4):540-5. PubMed ID: 24578243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 18F-fluoro-L-thymidine and 11C-methylmethionine as markers of increased transport and proliferation in brain tumors.
    Jacobs AH; Thomas A; Kracht LW; Li H; Dittmar C; Garlip G; Galldiks N; Klein JC; Sobesky J; Hilker R; Vollmar S; Herholz K; Wienhard K; Heiss WD
    J Nucl Med; 2005 Dec; 46(12):1948-58. PubMed ID: 16330557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histomolecular Validation of [
    Vindstad BE; Skjulsvik AJ; Pedersen LK; Berntsen EM; Solheim OS; Ingebrigtsen T; Reinertsen I; Johansen H; Eikenes L; Karlberg AM
    Cancers (Basel); 2024 Jul; 16(14):. PubMed ID: 39061219
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Michaud L; Beattie BJ; Akhurst T; Dunphy M; Zanzonico P; Finn R; Mauguen A; Schöder H; Weber WA; Lassman AB; Blasberg R
    Eur J Nucl Med Mol Imaging; 2020 Jun; 47(6):1353-1367. PubMed ID: 31418054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trans-1-amino-3-18F-fluorocyclobutanecarboxylic acid (anti-18F-FACBC) is a feasible alternative to 11C-methyl-L-methionine and magnetic resonance imaging for monitoring treatment response in gliomas.
    Sasajima T; Ono T; Shimada N; Doi Y; Oka S; Kanagawa M; Baden A; Mizoi K
    Nucl Med Biol; 2013 Aug; 40(6):808-15. PubMed ID: 23701701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of effects of 18F-FDG PET-CT and MRI in identifying and grading gliomas.
    Song PJ; Lu QY; Li MY; Li X; Shen F
    J Biol Regul Homeost Agents; 2016; 30(3):833-838. PubMed ID: 27655507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective trial evaluating the sensitivity and specificity of 3,4-dihydroxy-6-[18F]-fluoro-L-phenylalanine (18F-DOPA) PET and MRI in patients with recurrent gliomas.
    Youland RS; Pafundi DH; Brinkmann DH; Lowe VJ; Morris JM; Kemp BJ; Hunt CH; Giannini C; Parney IF; Laack NN
    J Neurooncol; 2018 May; 137(3):583-591. PubMed ID: 29330751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.